Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z

National Center for Infectious Diseases
Division of Viral and Rickettsial Diseases
DVRD Home

Program Contents
About DVRD
Disease Information
Publications
  1998
  1997
  1996

Other Links
CDC Homepage
NCID Homepage
External Links
logo: National Library of MedicineObtain abstract and/or full text of research articles below from PubMed online.
From the National Library of Medicine

 

Publications - 1999

 

Articles, Reports, and Book Chapters

  1. Abbott K, Ksiazek T, Mills JN. Long-term hantavirus persistence in rodent populations in central Arizona. Emerg Infect Dis 1999;5:102-12.

  2. Aggarwal R, McCaustland KA, Dilawari JB, Sinha SD, Robertson BH. Genetic variability of hepatitis E virus within and between three epidemics in India. Virus Research 1999; 59:35-48.
  3. Alfieri AA, Leite JPG, Alfieri AF, Jiang B, Glass RI, Gentsch JR. Detection of field isolates of human and animal group C rotavirus by reverse transcription-polymerase chain reaction and digoxigenin-labeled oligonucleotide-probes. J Virol Meth 1999;83:35_43.
  4. Alpern HL, Ranavaya MI, Govindan S, Hauser CJ, Jessen B, Komaroff AJ, Lapp C, Make B, Mehta M, Scott M, Sietsema K, Stewart J. Chronic fatigue syndrome: Impairment and disability issues. AADEP position paper. Disability 1999;8:S1-12.
  5. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-62.
  6. Anderson L, Zaki SR, Torok TJ. Parvovirus infections (Erythema infectiosum). In: Wilfer C, ed.. Volume VIII, Pediatric Infectious Diseases. Philadelphia: Curr Med 1999: 3.1-3.20.
  7. Arao Y, Schmid DS, Pellett PE, Inoue N. Herpesviruses beyond HSV-1 and HSV-2. Clin Microbiol Newsletter 1999;21:153-9.
  8. Arguin PM, Singleton J, Rotz LD, Marston E, Treadwell TA, Slater K, Chamberland M, Schwartz A, Tengelsen L, Olson JG, Childs JE, and the Transfusion-associated Tick-borne Illness Task Force. An investigation into the possibility of transmission of tick-borne pathogens via blood transfusion. Transfusion 1999;39:828-33.
  9. Arguin PM, Rupprecht CE. Animal bites and rabies. In: Armstrong D, Cohen J, eds. Infectious Diseases. Mosby, Philadelphia; 1999: pp. 6151-4.
  10. Armstrong LR, Derkay CS, Reeves WC, and the Recurrent Respiratory Papillomatosis Task Force. Initial results from the National Registry for Recurrent Respiratory Papillomatosis. Arch Otolaryngol Head Neck Surg 1999;125:743-8.
  11. Armstrong LR, LM Dembry, PM Rainey, MB Russi, AS Khan, SH Fischer, SC Edberg, TG Ksiazek, PE Rollin, CJ Peters. Management of a Sabiá-infected patient in a U.S. hospital. Infect Control Hosp Epidemiol 1999.1999;20:176-82.
  12. Auwaerter P, Rota P, Elkins R, et al. Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different strains. J Infect Dis 1999;180:950-8.
  13. Belay ED. Transmissible spongiform encephalopathies in humans. Annu Rev Microbiol 1999:53:283-314.
  14. Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Reye syndrome in the United States, 1981-1997. N Engl J Med 1999;340:1377-82.
  15. Belay ED, Schonberger LB. Reye’s syndrome [letter]. N Engl J Med 1999;341:846.
  16. Bender C, Hall H, Huang J, Klimov A, Subbarao K. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology 1999;254:115-23.
  17. Bennett SG, Webb JP Jr, Madon MB, Childs JE, Ksiazek TG, Torrez-Martinez N, Hjelle B. 1999. Hantavirus (Bunyaviridae) infections in rodents from Orange and San Diego Counties, California. Am J Trop Med Hyg, 60:75-84.
  18. Berry DS, Miller RS, Hooke JA, Massung RF, Bennett J, Ottolini MG. Ehrlichial meningitis with cerebrospinal fluid morulae. Pediatr Infect Dis J 1999;18:552-5.
  19. Bitnun A, Shannon P, Durward A, et al. Measles inclusion body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis 1999;29:855-61.
  20. Birkness KA, Deslauriers M, Bartlett JH, White EH, King CH, Quinn FD. An in vitro tissue culture bilayer model to examine early events in mycobacterium tuberculosis infection. Infection and Immunity 1999; 67:653-8.
  21. Birkness KA, Swords WE, Huang P-H, White EH, Dezzutti CS, Lal RB, et al. Observed differences in virulence-associated phenotypes between a human clinical isolate and a veterinary isolate of mycobacterium ovium. Infect Immunity 1999; 67:4895-901.
  22. Bjoersdorff A, Brouqui P, Eliasson I, Massung RF, Wittesjo B, Berglund J. Serological evidence of Ehrlichia infection in Swedish Lyme borreliosis patients. Scand J Infect Dis 1999;31:51-5.
  23. Bjoersdorff A, Svendenius L, Owens JH, Massung RF. Feline granulocytic ehrlichiosis--a report of a new clinical entity and characterisation of the infectious agent. J Small Anim Pract 40:20-4.
  24. Black JB, Pellett PE. Human herpesvirus 7. Rev Med Virol 1999;9:245-62.
  25. Black JB, Pellett PE. Antiviral screening assays for human herpesviruses 6 and 7. In: Kinchington D, Schinazi R, eds. Methods in Cellular and Molecular Biology: Antiviral Evaluation. Humana Press, 1999:129-38.
  26. Blydt-Hansen T, Subbarao K, Quennec P, McDonald J. Recovery of respiratory syncytial virus from stethoscopes by conventional culture and polymerase chain reaction. Pediatr Infect Dis J 1999;18:164-5.
  27. Brandsma AR, Little S.E., Lockhart J.M., Davidson WR, Stallknecht DE, Dawson JE. Novel Ehrlichia organism (Rickettsiales: Ehrlichiae) in white-tailed deer associated with Lone Star tick (Acari: Ixodidae) parasitism. J Med Entomol 1999; 36:194.
  28. Breman JG, Johnson KM, van der Groen G, Robbins CB, Szczeniowski MV, Ruti K, Webb PA, Heyman DL, Krebs JW, et al. A search for Ebola virus in animals in Zaire and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. J. Infect. Dis. 1999;179(Supp 1):S139-47.
  29. Bresee JS, Glass RI. Astrovirus, enteric adenovirus and other enteric viral infections. In: Tropical Infectious Diseases: Principles, Pathogens, and Practice. New York: Churchill Livingstone, 1999:1145-53.
  30. Bresee J, Glass RI, Ivanoff B, Gentsch J. Current status and future priorities for rotavirus vaccine development, evaluation, and implementation in developing countries. Vaccine 1999;17:2207-22.
  31. Bresee,JS, Parashar UD, Gentsch JR, Glass RI. Rotavirus vaccines: review, rationale and prospects. Vaccines, children, and practice, volume 2, number 1:8_11 (SKB8_9541), 1999. Adis International Limited.
  32. Bridges CB. What we now know about the influenza virus. In: The College Board.
  33. The Spanish Flu and Its Legacy. College Board Publications, New York. 1999;127-32.
  34. Briggs D, Smith J, Mueller F, Schwenke J, Davis R, Gordon C, Schwitzer K, Orciari L, Yager P, Rupprecht C. A comparison of two serological methods for detecting the immune response after rabies vaccination in dogs and cats being exported to rabies-free areas. Biologicals 1998;26:347-55.
  35. Brown B, Oberste M, Alexander J, Kennett M, Pallansch M. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 1999;73:9969-75.
  36. Brown MP, Nosaka T, Tripp RA, et al. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3. Blood 1999;94:1906-14.
  37. Buffington J. Prevention and control of viral hepatitis: the facts about sexual, perinatal and household transmission. The Female Patient 1999; 24: 41-8.
  38. Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikihisa Y, Unver A, Gaudreault-Keener M, Manian FA, Liddell AM, Schmulewitz N, Storch GA. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 1999;341:148-55.
  39. Bunnell R, Dahlberg L, Rolfs R, Ransom R, Gershman K, Farshy C, Newhall J, Schmid S, Stone K, St Louis ME. High prevalence and incidence of STDs in urban adolescent females despite modest risk behaviors. J Infect Dis 1999;180: 1624-31.
  40. Busch M, Chamberland M, Epstein J, Kleinman S, Khabbaz R, Nemo G. Oversight and monitoring of blood safety in the United States. Vox Sang 1999;77:67-76.
  41. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. Predicting the evolution of human influenza A. Science 1999;286:1921-5.
  42. Bush RM, Fitch WM, Bender CA, Cox NJ. Positive selection on the H3 hemagglutinin gene of human influenza A virus. Mol Biol Evol 1999;16:1457-65.
  43. Busico KM, Marshall KL, Ksiazek TG, Roels TH, Fleerackers Y, Feldmann H, Rollin PE, Khan AS, Peters CJ. Prevalence of IgG antibodies to Ebola-Zaire in healthy individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(Suppl 1):S102-7.
  44. Bwaka MA, Bonnet M_J, Calain P, Colebunders R, De Roo A, Guimard Y, Katwiki KE, Kibadi KK, Kipasa MA, Kuvula KJ, Mapanda BB, Massamba M, Mupapa KD, Muyembe J-J, Ndaberey E, Peters CJ, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo (former Zaire): clinical observations in disease. J Infect Dis 1999;179 (Supp l):S1-7.
  45. Calain P, Monroe MC, Nichol ST. Ebola virus defective interfering particles and persistent infection. Virology 1999;262:114_28.
  46. Calisher CH, Sweeney W, Mills JN, Beaty BJ. Natural history of Sin Nombre virus in western Colorado. Emerg Infect Dis 1999; 5:126-34.
  47. Calderon G, Pini N, Bolpe J, Levis S, Mills J, Segura E, Guthmann N, Cantoni G, Becker J, Fonollat A, Ripoll C, Bortman M, Beneditti R, Sabattini M, Enria D. Hantavirus reservoir hosts are associated with peridomestic habitats in Argentina. Emerg Infect Dis 1999;5:792-7.
  48. Cama RI, Parashar UD, Taylor DN, et al. Enteropathogens and other factors associated with severe disease in children with acute watery diarrhea in Lima, Peru. J. Infect. Dis. 1999;179:1139-44.
  49. Centers for Disease Control and Prevention. (Schonberger LB, author). Bovine spongiform encephalopathy and new variant Creutzfeldt-Jakob disease. In: Health Information for International Travel 1999-2000. National Center for Infectious Diseases: Atlanta. 1999:171-2.
  50. Chamberland ME. Surveillance for bloodborne infections. Thrombosis Haemostasis 1999;82:494-9.
  51. Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT, Holman RC, Christenson JC, Rubin PJ, Behrman RE, Wilson Bell LJ, Simpson GL, Sadek RF, and the Ribavirin Study Group. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during one year of open label experience. Antiviral Therapy 1999; 4:211-9.
  52. Chang JC, Ruedinger B, Cong M, Lambert S, Lopareva E, Purdy M, Holloway BP, Jue DL, Ofenloch B, Fields HA, Khudyakov YE. Artificial NS4 mosaic antigen of hepatitis C virus. J Med Virol 1999; 59:437-50.
  53. Chang JC, Seidel C, Ofenloch B, Jue DL, Fields HA, Khudyakov YE. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides. Virology 1999; 257: 177-90.
  54. Childs JE, Bryan RT. The epidemiology of HPS. In: Manual of hemorrhagic fever with renal syndrome. Lee HW, Calisher C, Schmaljohn CS, eds. WHO Collaborating Center for Virus Reference (Hantaviruses) and Research Asian Institute for Life Sciences, Seoul; 1999;63-73.
  55. Childs JE, Ellis BA, Nicholson WL, Kosoy M, Sumner JW. 1999. Shared vector-borne zoonoses of the Old World and New World: home grown or translocated? Schweiz Med Wochenschr 129:1099-1105.
  56. Childs JE, McQuiston J, Sumner JW, Nicholson WL, Comer JA, Massung RF, Standaert SM, Paddock CD. Human monocytic ehrlichiosis due to Ehrlichia chaffeensis: how do we count the cases? In: Rickettsiae and Rickettsial Diseases at the Turn of the Third Millnium. Raoult D, Brouqui P (eds), Elsevier, Paris, 1999:287-93.
  57. Childs JE, Strickland, GT. Zoonotic Diseases. In: Hunter’s Tropical Diseases, 8th edition. Strickland GT ed. Saunders, Philadelphia;1999: 979-84.
  58. Childs JE, Sumner JW, Nicholson WL, Massung RF, Standaert SM, Paddock CD. 1999. Outcome of diagnostic tests using samples from culture-proven cases of human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol, 37:2997-3000.
  59. Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PSK, Ksiazek TG, et al. Fatal encephalitis due to a new paramyxovirus among pig farmers in Malaysia. Lancet 1999; 354:1257-9.
  60. Clark HF, Glass RI, Offit PA. Rotavirus vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia: W.B.Saunders Company, 1999:987-1005.
  61. Chudy M, Budek I, Keller-Stanislawski B, McCaustland KA, Neidhold S, Robertson BH, Nubling M, Seitz R, Lower J. A new cluster of hepatitis A infections in haemophiliacs molecularly traced back to a contaminated plasma pool. J Med Virol 1999;57:91-9.
  62. Chung YH, Di Bisceglie AM, McMahon BJ, Lanier AP, Harpster A, Alter MJ, Parkinson AJ, Zanis C. Hepatocellular carcinoma not related to hepatitis B virus infection among Alaska Natives. Int J Circumpolar Health 1999;58:208_13.
  63. Clemens J, Keckich N, Naficy A, Glass R, Rao M. Public health considerations for the introduction of new rotavirus vaccines for infants: a case study of tetravalent rhesus rotavirus-based reassortant vaccine. Epidemiolog Rev 1999;21:24-42.
  64. Codo-Glez CJ, Juarez-Figueroa L, Uribe-Salas F, Hernandez-Nevarez P, Schmid DS, Calderon E, Hernendez-Avila M. Determination of prevalence of antibodies for herpes simplex virus type 1 and 2 in women with high risk sexual practices. Int J Epidem 1999;28:571-6.
  65. Cong M-E, Fried MW, Lambert S, Lopareva EN, Zhan M, Pujol FH, Thyagarajan SP, Byun KS, Fields HA, Khudyakov YE. Sequence heterogeneity within three different regions of the hepatitis G virus genome. Virology 1999; 255, 250-9.
  66. Comer JA, Nicholson WL, Olson JG, Childs JE. Serologic testing for human granulocytic ehrlichiosis (HGE) at a national referral center in the United States, 1987-1997. J Clin Microbiol, 1999;37:558-64.
  67. Comer JA, Nicholson WL, Sumner JW, Olson JG, Childs JE. Diagnosis of human ehrlichiosis by PCR assay of acute-phase serum. J Clin Microbiol 1999;37:31-4.
  68. Comer JA, Tzianabos T, Flynn C, Vlahov D, Childs JE. Serologic evidence of rickettsialpox (Rickettsia ackari) infection among intravenous drug users in inner-city Baltimore. Am J Trop Med Hyg 1999:60:894-8.
  69. Coulson BS, Gentsch JR, Das BK, Bhan MK, Glass RI. Comparison of enzyme immunoassay and reverse transcriptase PCR for identification of serotype G9 rotaviruses. J Clin Microbiol 1999;37:3187-93.
  70. Cox N. Prevention and control of influenza. Lancet 1999;354:siv30.
  71. Cox N, Subbarao K. Influenza. Lancet 1999;354:1277-82.
  72. Cox NJ, Hughes JM. New options for the prevention of influenza. N Engl J Med 1999;341:1387_8.
  73. Cunliffe NA, Gondwe JS, Broadhead RL, Molyneux ME, Woods PA, Bresee JS, Glass RI, Gentsch JR. Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol 1999;57:308-12.
  74. David D, Rupprecht CE, Smith J, Samina I, Perl S, Shram Y. Human rabies in Israel [letter]. Emerg Infect Dis 1999;5:306_8.
  75. de Mattos CC, de Mattos C.A, Loza-Rubio E. Aguilar-Setién, A., Orciari LA, Smith J S. Molecular characterization of rabies virus isolates from Mexico: implications for transmission dynamics and human risk. Am J Trop Med Hyg 1999;61:587-97.
  76. De Serres G, Cromeans T L, Levesque B, Brassard N, Barthe C, Dionne M, Prud’homme H, Paradis D, Shapiro CN, Nainan OV, Margolis HS. Molecular confirmation of hepatitis A from well water: epidemiology and public health implications. J Infect Dis 1999; 179:37-43.
  77. des Vignes F, Levin ML, Fish D. Comparative vector competence of Dermacentor variabilis and Ixodes scapularis (Acari: Ixodidade) for the agent of human granulocytic ehrlichiosis. J Med Entomol 1999;36:182-5.
  78. Dobbins JG, Mastro TD, Nopkesorn T, Limpakarnjanarat K, Weniger B, Schmid DS. Herpes in the time of AIDS: A comparison of the epidemiology of HSV-2 and HIV-1 in young men in northern Thailand. Sex Trans Dis 1999;26:67-74.
  79. Dominguez, G., T.R. Dambaugh, F.R. Stamey, S. Dewhurst, N. Inoue, and P.E. Pellett. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol1999;73:8040-52.
  80. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ, for the Commission de Lutte contre les Epidémies à Kikwit. Transmission of Ebola hemorrhagic fever: A study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(Suppl 1):S87-91.
  81. Drenzek C, Rupprecht CE. The rabies pandemic. In: Kirk's Current Veterinary Therapy XIII Small Animal Practice. J. D. Bonagura, ed.. W.B. Saunders Co., Philadelphia;1999:294-5.
  82. Drobeniuc J, Hutin YJ, Harpaz R, Favorov M, Melnik A, Iarovoi P, Shapiro CN, Woodruff BA. Prevalence of hepatitis B, D, and C virus infections among children and pregnant women in Moldova: additional evidence supporting the need for routine hepatitis B vaccination of infants. Epidemiol Infect 1999;123:463_7.
  83. Ellis BA, Regnery RL, Beati L, Bacellar F, Glass GE, Marston E, Ksiazek TG, Jones D, Childs JE. Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella: an Old World origin for a New World disease? J Infect Dis 1999;180: 220-4.
  84. Ellis BA, Rotz LD, Leake JAD, Salmalvides F, Bernable J, Ventura G, Padilla C, Villaseca P, Beati L, Regnery R, Childs JE, Olson JG, Carrillo, CP. An outbreak of acute bartonellosis (Oroya fever) in the Urubamba region of Peru, 1998. Am J Trop Med Hyg 1999 61:344-9.
  85. Enria D, Bowen M, Mills JN, Shieh W-J, Bausch D, Peters CJ. Arenaviruses. In: Guerrant R, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens, and Practice. New York:WB Saunders, 1999:1189-212.
  86. Erdman DD, Anderson LJ. Human parvovirus B19. In: Lennette EH, Smith TF, eds. Laboratory diagnosis of viral infections. 3rd ed. New York: Marcel Dekker, Inc, 1999:703-19.
  87. Favorov MO, Kosoy MY, Tsarev SA, Childs JE, Margolis HS. Prevalence of antibody to hepatitis E virus among rodents from the United States. J Infect Dis 1999;181:449-55.
  88. Favorov MO, Margolis HS. Hepatitis E virus infection: an enterically transmitted cause of hepatitis. In: Emerging Infections 3 (Scheld WM, Craig WA, Hughes JM, eds), ASM Press, Washington DC, 1999; 1-16.
  89. Favero MS, Tokars JI, Arduino MJ, Alter MJ. Nosocomial infections associated with hemodialysis. In Hospital Epidemiology and Infection Control (Mayhall GC ed) Lippincott, Philadelphia 1999; 897-917.
  90. Feikin DR, Moroney JF, Talkington DF, et al. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a Federal Service Training Academy: new implications from an old scenario. Clin Infect Dis 1999;29:1545-50.
  91. Fishman P, Shay D. Development and estimation of a pediatric chronic disease score using automated pharmacy data. Med Care 1999;37:874-83.
  92. Frace AM, Klimov AI, Rowe T, Black RA, Katz JM. Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 1999;17:2237-44.
  93. Frieden TR, Ozick L, McCord C, Nainan OV, Workman S, Comer G, Lee T-P, Byun K-S, Patel D, Henning KJ. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis. Hepatology 1999;29: 883-8.
  94. Fuller J, Craven, Donald E, Steger, Kathleen A, Cox, Nancy, Heeren, Timothy C, Chernoff, David. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type I RNA and determinants of antibody response. Clin Infect Dis 1999;28:541-7.
  95. Fulhorst CF, Bowen MD, Salas RA, Duno G, Utrera A, Ksiazek TG, DeManzione NM, De Miller E, Vasquez C, Peters CJ, Tesh RB. Natural rodent host associations of Guanarito and Pirital viruses (Family Arenaviridae) in central Venezuela. Am J Trop Med Hyg 1999;61:325-30.
  96. Fulhorst CF, Ksiazek TG, Peters CJ, Tesh RB. Experimental infection of the cane mouse
  97. Zygodontomys brevicauda (family Muridae) with guanarito virus (Arenaviridae), the etiologic agent of Venezuelan hemorrhagic fever. J Infect Dis 1999;180:966-9.
  98. Gensheimer KF, Fukuda K, Brammer L, Cox N, Patriarca PA, Strikas RA. Preparing for pandemic influenza: the need for enhanced surveillance. Emerg Infect Dis 1999;5:1-3.
  99. Glass R. Commentary. Reanalysis of the results of two rotavirus vaccine trials: an appraisal of the reappraisal. Pediatr Infect Dis J 1999;18:1006-7.
  100. Glass RI. Review of rotavirus vaccine trials, results, and lessons. Rotavirus proceedings presented at the 14th Annual Meeting of the European Society for Pediatric Infectious Diseases, June 1996. Elsinore, Denmark: 1999:18-21.
  101. Glass RI, Belliot G, Ivanoff B, Parashar U, Gentsch J, Bresee J. La prevention des diarrhees a rotavirus par la vaccination. [Prevention of diarrhea by vaccination.] Arch Pediatr 1999;6:323-6.
  102. Glass RI, Bresee J, Parashar U, Gentsch J. Prevention of rotavirus diarrhea with vaccines. Concise review. (Harrison's On Line. Related to Section 14, Part 7, Chapter 194, Viral Gastroenteritis. Harry Greenberg. [www.harrisonsonline.com/...ed1238]).
  103. Glass RI, Bresee JS, Parashar UD, Holman RC, Gentsch JR. First rotavirus vaccine licensed: is there really a need? Acta Paediatrica. (Suppl) 1999;88:2_8.
  104. Goldsmith CS, Shieh WJ, Pallansch MA, Ksiazek TG, Hsueh C, Jung SM, et al. Fatal encephalitis in young children, Taiwan, 1998. Microscopy Microanalysis 1999; 5:1146-7.
  105. Guarner J, Greer PW, Bartlett J, Ferebee T, Fears M, Pope V, et al. Congenital syphilis in a newborn: An immunopathologic study. Modern Pathol 1999;12:82-7.
  106. Guarner J, Greer PW, Bartlett J, Shieh W-J, Zaki SR. Immunohistochemical detection of Francisella tularensis in formalin-fixed paraffin-embedded tissue. Applied Immunohistochemical Molecular Morphology 1999; 7:122-6.
  107. Guarner J, Herrera-Goepfert R, Mohar A, Sanchez L, Halperin D, Ley C, et al. Interobserver variability in application of the revised Sydney classification for gastritis. Human Pathol 1999; 30:1431-4.
  108. Halsey NA, Moulton LH, O’Donovan JC, Walcher JR, Thoms ML, Margolis HS, Krause DS. Hepatitis B vaccine administered to children and adolescents at yearly intervals. Pediatrics 1999; 103:1243-7.
  109. Halsey NA, Duclos P, VanDamme P, Margolis HS. Hepatitis B vaccine and central nervous system demyelinating diseases. Pediatr Infect Dis J 1999; 18:23-4.
  110. Khudyakov YE, Lopareva EN, Jue DL, Crews T, Thyagarajan SP, Fields HA. Antigenic domains of the open reading frame 2 encoded protein of the hepatitis E virus. J Clin Microbiol 1999; 37:2863-71.
  111. Khudyakov YE, Lopareva EN, Jue DL, Fang S, Spelbring J, Krawczynski K, Margolis HS, Fields HA. Antigenic epitopes of the hepatitis A virus polyprotein. Virology 1999; 260: 260-72.
  112. Hamir AN, Dubey JP, Rupprecht CE. Prevalence of Sarcocystis kirkpatricki Sarcocysts in the central nervous system and striated muscles of raccoons from the eastern United States. J Parasitol 1999; 85:748_50.
  113. Hamir AN, Lehmann B, Raju N, Ebel JG, Manzell KL, Rupprecht CE. Experimental lead toxicosis of raccoons (Procyon lotor). J Comp Path 1999;120:147-54.
  114. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999;179:25-30.
  115. Hanlon CA, Childs JE, Nettles VF, and the National Working Group on Rabies Prevention and Control. Prevention and control of rabies in the United States: recommendations of a national working group. Article III: Rabies in wildlife. J Am Vet Med Assoc 1999;215:1612-8.
  116. Hanlon CA, Olson JG, Clark CJ, and the National Working Group on Rabies Prevention and Control. Prevention and control of rabies in the United States: recommendations of a national working group. Article I: Prevention and education regarding rabies in human beings. J Am Vet Med Assoc 1999;215:1276-80.
  117. Hanlon CA, Smith JS, Anderson GR, and the National Working Group on Rabies Prevention and Control. Prevention and control of rabies in the United States: recommendations of a national working group. Article II: Laboratory diagnosis of rabies. J Am Vet Med Assoc 1999;215:1444-6.
  118. Harcourt B, Rota P, Hummel K, Bellini W, Offermann M. Induction of intercullular adhesion molecule 1 gene expression by measles virus in human umbilical vein endothelial cells. J Med Virol 1999;57:9-16.
  119. Harrison LH, Halsey NA, McKee KT Jr, Peters CJ, Barrera Oro JG, Briggiler AM, Feuillade
  120. MR, Maiztegui JI. Clinical case definitions for Argentine hemorrhagic fever. Clin Infect Dis 1999;28:1091-4.
  121. Helfand R, Kebede S, Gary H, Bellini W. The timing of the development of measles-specific IgM and IgG after primary measles vaccination. Clin Diagn Lab Immunol 1999;6:178-80.
  122. Hofmeister EK, Ellis BA, Glass GE, Childs JE. Longitudinal study of infection with Borrelia burgdorferi in a population of Peromyscus leucopus at a Lyme disease enzootic site in Maryland. Am J Trop Med Hyg 1999;60:598-609.
  123. Hofmeister EK, Glass GE, Childs JE, Persing DH. Population dynamics of a naturally occurring heterogeneous mixture of Borrelia burgdorferi clones. Infect Immun 1999;67:5709-16.
  124. Holman RC, Belay ED, Clarke MJ, Kaufman SF, Schonberger LB. Kawasaki syndrome among American Indian and Alaska Native children, 1980 through 1995. Pediatr Infect Dis J 1999;18:451-5.
  125. Holman RC, Parashar UD, Clarke MJ, Kaufman SF, Glass RI. Trends of diarrhea-associated hospitalizations among American Indian and Alaska Native children, 1980-1995. Pediatrics (electronic) 1999;103:e11.
  126. Holmes JL, Kirkwood CD, Gerna G, et al. Characterization of unusual G8 rotavirus strains isolated from Egyptian children. Arch Virol 1999;144:1381-96.
  127. Howard MJ, Doyle TJ, Frederick TK, Zaki SR, Bryan RT. Hantavirus pulmonary syndrome in pregnancy. Clin Infect Dis 1999; 29:1538-44.
  128. Humphrey CD. Successful management of infectious disease pathogens from microbial outbreak specimens: safety and identification. Microscopy Microanalysis 1999; 5:1184-5.
  129. Hutin YJ, Bell BP, Marshall KL, Schaben CP, Dart M, Quinlisk MP, Shapiro CN. Identifying target groups for a potential vaccination program during a hepatitis A communitywide outbreak Am J Public Health 1999;89:918_21.
  130. Hutin YJ, Goldstein ST, Varma JK, O’Dair JB, Mast EE, Shapiro CN, Alter MJ. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol 1999;20:731-5.
  131. Hutin YJ, Harpaz R, Drobeniuc J, Melnic A, Ray C, Favorov M, Iarovoi P, Shapiro CN. Woodruff BA. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 1999;28:782_6.
  132. Hutin YJF, Pool V, Cramer EH, Nainan OV, Weth J, Williams IT, Goldstein ST, Gensheimer KF, Bell BP, Shapiro CN, Alter MJ, Margolis HS for the National Hepatitis A Investigation Team. A multistate foodborne outbreak of hepatitis A identified and characterized using epidemiology and genetic analysis. N Engl J Med 1999; 340:595-602.
  133. Ivanoff B, Glass RI. Vaccins contre les infections a rotavirus: efficacite et place eventuelle dans les programmes de vaccination. Arch Pediatr 1999;6(Suppl. 3):330-1.
  134. Jaffe HW, Pellett PE. Human herpesvirus 8 and Kaposi’s sarcoma – some answers, more questions. N Engl J Med 1999;340:1912-3.
  135. Jahrling PB, Geisbert TW, Geisbert JB, Swearengen JR, Bray M, Jaax NK, Huggins JW, LeDuc JW, Peters CJ. Evaluation of immune globulin and recombinant interferon alpha_2b for treatment of experimental Ebola virus infections. J Infect Dis 1999;179 (Supp l):S224-34.
  136. Jiang B, Gentsch JR, Tsunemitsu H, Saif LJ, Glass RI. Sequence analysis of the gene encoding VP4 of a bovine group C rotavirus: molecular evidence for a new P genotype. Virus Genes 1999;19:85-8.
  137. Johnson AM, deSouza LTM, Ferreira IB, Pereira LE, Ksiazek TG, Rollin PE, Peters CJ, Nichol ST. Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol 1999 59:527-35.
  138. Jones TF, Craig AS, Paddock CD, Mckechnie DB, Childs JE, Zaki SR, et al. Family cluster of rocky mountain spotted fever. Clin Infect Dis 1999; 28:853-9.
  139. Jones L, Erdman DD, Anderson L. Prevalence of antibodies to human parovirus B19 nonstructural protein (NS1) in persons with varied clinical outcomes following B19 infection. J Infect Dis 1999;180:500-4.
  140. Kalongi Y, Mwanza K, Tshisuaka M, Lusiama N, Ntando E, Kanzake L, Shieh W-J, Zaki SR, Lloyd ES, Ksiazek TG, Rollin PE. Isolated case of Ebola hemorrhagic fever with mucormycosis complications, Kinshasa, Democratic Republic of Congo. J Infect Dis 1999;179 (suppl 1): S28-S35.
  141. Katz JM, Lim W, Bridges CB, Rowe T, Hu-Primmer J, Lu X, Abernathy RA, Clarke M, Conn L, Kwong H, Lee M, Au G, Ho YY, Mak KH, Cox NJ, Fukuda K. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household contacts. J Infect Dis 1999;180:1763-70.
  142. Kellerman S. Alter MJ. Preventing hepatitis B and hepatitis C virus infections in end_stage renal disease patients: back to basics. Hepatology 1999;29:291_3.
  143. Keysary A, Amram L, Keren G, Sthoeger Z, Potasman I, Jacob A et al. Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Emerg Infect Dis 1999; 5:775-8.
  144. Khabbaz RF. Emerging viral infections. Adv Pediatr Infect Dis 1999;14:1_27.
  145. Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiëns B, Fleerackers Y, Kilmarx PH, Rodier GR, Nkuku O, Rollin PE, Sanchez A, Zaki SR, Swanepoel R, Tomori O, Nichol ST, Peters CJ, Muyembe-Tamfum JJ, Ksiazek TG, for the Commission de Lutte contre les Epidémies à Kikwit. The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(suppl 1):S76-86.
  146. Kirkwood CD, Gentsch JR, Glass RI. Sequence analysis of the NSP4 gene from human rotavirus strains isolated in the United States. Virus Genes 1999;19:113_22.
  147. Kirkwood CD, Gentsch JR, Hoshino Y, Clark HF, Glass RI. Genetic and antigenic characterization of a serotype P[6]G9 human rotavirus strain isolated in the United States. Virology 1999;256:45-53.
  148. Kiseleva IV, Egorov AY, Alexandrova GI, Aksenov OA, Osipova ZA, Maiorova LP, Klimov AI. Anti-tumor activity of cold-adapted influenza virus strains for continuous mouse tumor cell lines (Russian). Voprosy Virusologii 1999;44:29-32.
  149. Kitsutani PT, Denton RW, Fritz CL, Murray RA, Todd RL, Pape WJ, Wyatt F J, Young JC, Khan AS, Peters CJ, Ksiazek TG. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg Infect Dis 1999 5:701-5.
  150. Klimov A, Simonsen L, Fukuda K, Cox N. Surveillance and impact of influenza in the United States. Vaccine 1999;17:S42-6.
  151. Kosoy MY, Regnery RL, Kosoya OI, Childs JE. Experimental infection of cotton rats with three naturally occurring Bartonella species. J Wildl Dis 1999;35:275-84.
  152. Krebs JW, Smith JS,, Rupprecht CE, Childs JE. 1999. Rabies surveillance in the United States during 1998. J Am Vet Med Assoc 1999;215:1786-98.
  153. Krebs JW. Rabies -- Ancient malady, new twists. In: Infections of Leisure, 2nd edition, Schlossberg D, ed. ASM Press: Washington, DC;1999:281-306.
  154. Ksiazek TG, Rollin PE, Williams AJ, Bressler D, Martin ML, Swanepoel R, Burt F, Leman PA, Khan AS, Rowe AK, Sanchez A, Peters CJ. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody response among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(Suppl 1):S177-87.
  155. Kulonen K, Fekadu M, Whitfield S. Warner CK. An evaluation of immunofluorescence and PCR methods for detection of rabies in archival carnoy-fixed, paraffin-embedded brain tissue. J Vet Med Series B 1999; 46:151-5.
  156. Lambert SB, Fields HA. The enterically transmitted hepatitis viruses. In: Laboratory Diagnosis of Viral Infections (3rd edition). (Lenette, Smith, eds.). Marcel Dekker, Inc., New York; 1999: 467-87.
  157. Lee SY, Mak KH, Saw TA. The avian flu (H5N1): one year on. Public Health Epidemiol Bull 1999:8.
  158. Leirs H, Mills JN, Krebs JW, Childs JE, Dudu A, Woollen N, Ludwig GE, Peters CJ, Ksiazek TG, et al. Search for the Ebola-reservoir in Kikwit: reflections on the vertebrate collection. J Infect Dis 1999;179 (Suppl 1):S155-S63.
  159. Levin ML, des Vignes F, Fish D. Disparity in the natural cycles of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis. Emerg Infect Dis 1999;5:204-8.
  160. Li S, Liu C, Klimov A, Subbarao K, Perdue ML, Mo D, Ji Y, Woods L, Hietala S, Bryant M. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J Infect Dis 1999;179:1132-8.
  161. Limpakarnjanarat K, Mastro TD, Saisorn S, Uthaivoravit W, Kaewkungwal J, Korattana S, Young NL, Morse SA, Schmid S, Weniger BG, Nieburg P. HIV-1 and other sexually transmitted infections in a cohort of female sex workers in Chiang Rai, Thailand. Sex Trans Infect 1999; 75:30-5.
  162. Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, Peters CJ. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 1999;285:397-400.
  163. Lloyd ES, Zaki SR, Rollin PE, Ksiazek TG, Calain P, Kondé MK et al. Long-term disease surveillance in Bandundu Region, Democratic Republic of the Congo (former Zaire): A model for early detection and prevention of Ebola hemorrhagic Fever. J Infect Dis 1999; 179:S274-80.
  164. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 1999; 73:5903-11.
  165. Lemon SM, Alter MJ. Viral hepatitis. In: Holmes KK, Mardh PA, Sparling PF, Lemon SM, Stamm WE, Piot P, Wasserheit JN (eds). Sexually Transmitted Diseases, third edition. McGraw-Hill, New York;1999: 361-84.
  166. Lyerla R, Kellerman S, Alter MJ. Hepatitis B and hemodialysis: the impact of universal precautions in preventing the transmission of bloodborne viruses Infect Control Hosp Epidemiol 1999;20:156_7.
  167. Mahanty S, Kalwar R, Rollin PE. Cytokine measurement in biological samples after physicochemical treatment for inactivation of biosafety level 4 agents. J Med Virol 1999;59:341-5.
  168. Mahy, BWJ, ed. Impact of viral diseases on the developing world. In: Advances in Virus Research, vol 53. San Diego: Academic Press, 1999.
  169. Mahy BWJ. Introduction. In: Advances in Virus Research, vol 53. San Diego: Academic Press, 1999: 3-4.
  170. Manor Y, Handsher R, Halmut T, et al. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J. Clin. Microbiol 1999;37:1670-5.
  171. Marston E, Finkel B, Regnery R, Winoto I, Graham R, Wignal S, Simanjuntak G, Olson J. Prevalence of Bartonella henselae and Bartonella clarridgeiae in an urban Indonesian cat population. Clin Diag Lab Immuno 1999;6:41-4.
  172. Maruyama T, Parren PWHI, Sanchez A, Rensink I, Rodriguez LL, Khan AS, Peters CJ, Burton DR. Recombinant human monoclonal antibodies to Ebola virus. J Infect Dis 1999;179(Suppl 1):S235-9.
  173. Marx A, Marston BJ, Erdman DD, et al. Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. Clin Infect Dis 1999;29:134-40.
  174. Marx A, Shay DK, Noel JS, et al. An outbreak of acute gastroenteritis in a geriatric long-term-care facility: combined application of epidemiological and molecular diagnostic methods. Infect. Control Hosp Epidemiol 1999;20:306-11.
  175. Massoudi MS, Bell BP, Paredes V, Insko J, Evans K, Shapiro CN. An outbreak of hepatitis A associated with an infected foodhandler. Public Health Rep 1999;114:157_64.
  176. Mast EE, Alter MJ. Viral hepatitis in the newborn infant. Sem Pediatric Infect Dis 1999;10:201-7.
  177.  
  178. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999;17:1730-3.
  179. Mazzulli T, Peret TCT, McGreer A, Cann D, MacDonald KS, Chua R, Erdman DD, Anderson LJ. Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. J Infect Dis 1999;180:1686-9.
  180. McQuiston JH, Childs JE. Rabies exposure and clinical disease in humans. In: Rabies Guidelines for Medical Professionals. Veterinary Learning Systems, Overland Park, Kansas;1999; 27-35.
  181. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976-1994. Am J Pub Health 1999; 89:14-18.
  182. McQuiston JH, Paddock CD, Holman RC, Childs JE. Human ehrlichioses in the United States. Emerg Infect Dis 1999;5:635-42.
  183. Meltzer M, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 1999;5:1-13.
  184. Meng Y-X, Pellett PE. 1999. Herpesviruses: human herpesviruses 6, 7, and 8. In: Ahmed R, Chen I, eds. Persistent viral infections. New York: John Wiley and Sons. 1999:269-96.
  185. Mead PS. Slutsker L. Dietz V. McCaig LF. Bresee JS. Shapiro C. Griffin PM. Tauxe RV. Food_related illness and death in the United States. Emerg Infect Dis 1999;5:607_25.
  186. Meng J, Cong M-E, Pillot J, Dai X, Purdy MA, Fields HA, Khudyakov YE. (1999). Primary structure of open reading frame 2 and 3 of the hepatitis E virus isolated from Morocco J Med Virol 199; 57:126-33.
  187. Meng, Y.-X., Spira TJ, Bhat GJ, Birch CJ, Druce JD, Edlin BR, Edwards R, Gunthel C, Newton R, Stamey F, Wood C, Pellett PE. Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology 1999;261:106-19.
  188. Meng J, Cong M-E, Pillot J, Dai X, Purdy MA, Fields HA, Khudyakov YE. (1999). Primary structure of open reading frame 2 and 3 of the hepatitis E virus isolated from Morocco J Med Virol 199; 57:126-33.
  189. Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 1999;33:356-60.
  190. Mills JN. The role of rodents in emerging human disease: examples from the hantaviruses and arenaviruses. In: Singleton G, ed. Ecologically based management of rodent pests in developing countries. Australian Centre for International Agricultural Research, Canberra 1999;134-60.
  191. Mills JN, McKee KT, Jr. South American hemorrhagic fevers. In: Strickland G. (ed). Hunter’s Tropical Medicine. WB Saunders, New York;1999: 279-81.
  192. Mills JN, Yates TL, Ksiazek TG, Peters CJ, Childs JE. Long-term studies of hantavirus reservoir populations in the southwestern United States: rationale, potential, and methodology. Emerg Infect Dis 1999;5:95-101.
  193. Miranda ME, Ksiazek TG, Retuya TJ, Khan AS, Sanchez A, Fulhorst CF, Rollin PE, Calaor AB, Manalo DL, Roces MC, Dayrit MM, Peters CJ. Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis 1999;179(Suppl 1):S115-9.
  194. Mitchell DK, Matson DO, Jiang XI, et al. Molecular epidemiology of childhood astrovirus infection in child care centers. J Infect Dis 1999;180:514-7.
  195. Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Motokazu M, Robertson BH. 1999. Hepatitis B virus genotype assignment using restriction fragment length polymporphism patterns. FEBS Letters 1999;450:66-71.
  196. Mohle-Boetani J, Matkin C, Pallansch M, et al. Viral meningitis in child care center staff and parents: an outbreak of echovirus 30 infections. Public Health Rep 1999;114:249-56.
  197. Monroe MC, Morzunov SP, Johnson AM, Bowen MD, Artsob H, Yates T, Peters CJ, Rollin PE, Ksiazek TG, Nichol ST. Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis 1999;5:75-85.
  198. Monroe SS. Astroviruses (Astroviridae). In: Webster RG, Granoff A, eds. Encyclopedia of Virology. Second Edition. New York: Academic Press, 1999:104-8.
  199. Montecalvo MA, Jarvis WR, Ulman J, et al. Infection control measures prevent transmission of vancomycin-resistant enterococci. Ann. Intern. Med. 1999;131:269-72.
  200. Mounts AW, Holman RC, Clarke MJ, Bresee JS, Glass RI. Trends in hospitalizations associated with gastroenteritis among adults in the United States, 1979-1995. Epidemiol Infect 1999;123:1-8.
  201. Mounts AW, Kwong H, Izurieta HS, Ho YY, Au TK, Lee M, Bridges CB, Williams SW, Mak KH, Katz J, Thompson WW, Cox NJ, Fukuda K. Case-control study of risk factors for avian influenza A(H5N1) diseases, Hong Kong, 1997. J Infect Dis 1999;180:505-8.
  202. Moyer LA, Mast EE, Alter MJ. Hepatitis C: Part I. Routine serologic testing and diagnosis. Am Fam Physician 1999;59:79-88, 91-2.
  203. Moyer LA, Mast EE, Alter MJ. Hepatitis C: Part II. Prevention counseling and medical evaluation. Am Fam Physician 1999;59:349-57.
  204. Naficy AB, Abu-Elyazeed R, Holmes JL, et al. Epidemiology of rotavirus diarrhea in Egyptian children and implications for disease control. Am J Epidemiol. 1999;150:770-7.
  205. Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics 1999;103:e3.
  206. Nicholson WL, Sumner JW, Castro M, Kramer VL, Childs JE. Dusky-footed woodrats (Neotoma fuscipes) as reservoirs of granulocytic ehrlichiae (Rickettsiales: Ehrlichieae) in northern California. J Clin Microbiol 1999;37:3323-7.
  207. Noel JS, Fankhauser RL, Ando T, Monroe SS, Glass RI. Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution. J Infect Dis 1999;179:1334-44.
  208. Oberste M, Maher K, Kennett M, Campbell JJ, Carpenter MS, Schnurr D, Pallansch MA. Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol 1999;37:3928-33.
  209. Oberste M, Maher K, Kilpatrick D, Pallansch M. Molecular evolution of human enteroviruses: Correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 1999;73:1941-8.
  210. Oberste M, Maher K, Pallansch M. Specific detection of echoviruses 22 and 23 in culture supernatants by RT-PCR. J Med Virol 1999;58:178-81.
  211. Olson JG. Bartonella-associated diseases. In: Hunter’s Tropical Medicine, eighth edition. Strickland GT. W.B. Saunders and Co., Orlando;1999:394.
  212. Olson JG. Epidemic typhus: a forgotten but lingering threat. In: Emerging Infections 3. Scheld WM, Craig WA, Hughes JM.. ASM Press, Washington, DC; 1999;67-72.
  213. Olson JG. Rickettsial infections--General principles. In: Hunter’s Tropical Medicine, eighth edition. Strickland GT. W.B. Saunders and Co., Orlando;1999:421-30.
  214. Olson JG. Q Fever. In: Hunter’s Tropical Medicine, eighth edition. Strickland GT. W.B. Saunders and Co., Orlando;1999:306-7.
  215. Olson JG, Paddock CD. Emerging rickettsioses. Infect Dis Rev 1999;1:113-4.
  216. Paddock CD, Greer PW, Ferebee TL, Singleton J, McKechnie DB, Treadwell TA, Krebs JW, Clarke MJ, Holman RC, Olson JG, Childs JE, Zaki SR. Hidden mortality due to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis 1999;179:1469-76.
  217. Paddock CD, Olson JG. Rickettsial and ehrlichial infections. In: Conn’s Current Therapy. Rakel RE, ed. WB Saunders and Co., Orlando; 1999:166-9.
  218. Parashar UD, Bennett JV, Boring JR, Hlady WG. Topical antimicrobials applied to the umbilical cord stump: a new intervention against neonatal tetanus. Int. J. Epidemiol. 1999;27:904-8.
  219. Parashar UD, Chung MA, Holman RC, Ryder RW, Hadler JL, Glass RI. Use of state hospital discharge data to assess the morbidity from rotavirus diarrhea and to monitor the impact of a rotavirus immunization program: a pilot study in Connecticut. Pediatrics 1999;104:489-94.
  220. Paton NI, Leo YS, Zaki SR, Wong MC, Lee KE, Ling AE, et al. Outbreak of Nipah virus infection among abattoir workers in Singapore. Lancet 1999; 354:1253-6.
  221. Pellett, P.E., T.J. Spira, O. Bagasra, C. Boshoff, L.Corey, L. de Lellis, M.-L. Huang, J.-C. Lin, S. Matthews, P. Monini, P. Rimessi, C. Sosa, C. Wood, J.A. Stewart. Multi-center comparison of polymerase chain reaction detection of human herpesvirus 8 DNA in semen. J Clin Microbiol 1999;37:1298-301.
  222. Peters CJ, Khan AS. Filovirus diseases. Curr Top Microbiol Immunol 1999;235:85-95.
  223. Peters CJ, LeDuc JW. An Introduction to Ebola: the virus and the disease, J Infect Dis 1999;179 (Supp l):S ix-xvi.
  224. Peters CJ, Mills JN, Spiropoulou C, Zaki SR, Rollin P. Hantaviruses. In: Guerrant RL, Krogstad DJ, Maguire JA, Walker DH, Weller PF, eds. Tropical Infectious Diseases. New York: Churchill Livingstone, 1999: 1217-35.
  225. Peters CJ, Simpson GL, Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med, 1999;50:531-45.
  226. Peters CJ, Zaki SR. Viral hemorrhagic fevers: Overview. In: Guerrant RL, Krogstad DJ, Maguire JA, Walker DH, Weller PF, eds. Tropical Infectious Diseases. New York: Chuchill Livingstone, 1999: 1182-90.
  227. Petrovec M, Sumner JW, Nicholson WL, Childs JE, Strle F, Barlie J, Lotri-Furlan, Avsic-Zupanc T. Identity among ehrlichial DNA sequences derived from Ixodes ricinus ticks with those obtained from patients with human granulocytic ehrlichiosis (HGE) in Slovenia. J Clin Microbiol 1999;37:209-10.
  228. Piper MA, Severin ST, Wiktor SZ, Unger ER, Ghys D, Miller D, Greenberg AE, Reeves WC, Vernon SD. The association of HIV-1, HIV-2 and CD4 cell-count on human papillomavirus DNA in women with low versus high numbers of sex partners. Sex Trans Infect 1999;75:253-7.
  229. Pittman PR, Liu CT, Cannon TL, Makuch RS, Mangiafico JA, Gibbs PH, Peters CJ. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. Vaccine 1999;18(1-2):181-9.
  230. Plotkin SA, Rupprecht CE, Koprowski H. Rabies vaccine. In: Vaccines, 3rd ed. Plotkin SA, Orenstein WA, eds. W.B. Saunders Co., Philadelphia;1999;743-66.
  231. Polish LB, BH Robertson, B Khanna, K Krawczynski, J Spelbring, F Olson, CN Shapiro. Excretion of hepatitis A virus in adults: A comparison of immunologic and molecular detection methods with infectivity in tamarins. J. Clin Microbiol 1999;37:3615-7
  232. Rajeevan MS, Dimulescu IM, Unger ER, Vernon SD. Chemiluminescent analysis of gene expression on high density filter arrays. J Histochem Cytochem 1999; 47:337-42.
  233. Raoult D, Olson JG. Emerging rickettsioses. In: Emerging Infections 3. Scheld WM, Craig WA, Hughes JM, eds. ASM Press, Washington, DC: 1999;17-35.
  234. Rechav Y, Zyzak M, Fielden LJ, Childs JE. Comparison of methods for introducing and producing artificial infection of Ixodid ticks with Ehrlichia chaffeensis. J Med Entomol 1999;36:414-9.
  235. Reiter P, Turell M, Coleman R, Miller B, Maupin G, Liz J, Kuehne A, Barth J, Geisbert J, Dohm D, Glick J, Pecor J, Robbins R, Jahrling P, Peters C, Ksiazek T. Field investigations of an outbreak of Ebola hemmorrhagic fever, Kikwit, Zaire, 1995. Arthropod Studies. J Infect Dis 1999;179 (Supp l):S148-54.
  236. Ripoll CM, Remondegui CE, Ordonez G, Arazamendi R, Fusaro H, Hyman MJ, Paddock CD, Zaki SR, Olson JG, Santos-Buch CA. Evidence of rickettsial spotted fever and ehrlichial infections in a subtropical territory of Jujuy, Argentina. Am J Trop Med. Hyg 1999;61:350-4.
  237. Robertson BH, Erdman DD. Non-enveloped viruses transmitted by blood and blood products. In: Advances in Transfusion Safety: Developments in Biological Standardization. Brown F, Vyas G, eds. 1999;102:29-35.
  238. Rollin PE, Williams J, Bressler B, Pearson S, Cottingham M, Pucak G, Sanchez A, Trappier SJ, Peters RL, Greer PW, Zaki S, Demarcus T, Hendricks K, Kelley M, Simpson D, Geisbert TW, Jahrling PB, Peters CJ, Ksiazek TJ. Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis 1999;179 (Supp l):S108-14.
  239. Puglielli MT, Browing JL, Schreiber RD, Shieh W-J, Brewer AW, Altman JD et al. Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin pathway. Nature Medicine 1999; 5:1370-4.
  240. Reyes M, Dobbins JG, Nisenbaum R, Subedar NS, Randall B, Reeves WC. Chronic fatigue syndrome progression and self-defined recovery: Evidence from the CDC surveillance system. J CFS 1999;5:17-27.
  241. Ripoll CM, Remondegui CE, Ordonez G, Arazamendi R, Fusaro H, Hyman M et al. Evidence of rickettsia spotted fever and ehrlichial infections in a subtropical territory of Jujuy, Argentina. Am J Trop Med Hyg 1999; 61:350-4.
  242. Robertson BH, Erdman DD. Non-enveloped viruses transmitted by blood and blood products. Advances in Transfusion Safety. (Development Biological Standards; vol 102). Basel, Karger, 1999.
  243. Rodriguez LL, De Roo A, Guimard Y, Trappier SG, Sanchez A, Bressler D, Williams AJ, Rowe AK, Bertolli J, Khan AS, Ksiazek TG, Peters CJ, Nichol ST. Persistence of genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(Suppl 1):S170-6.
  244. Roels TH, Bloom AS, Buffington J, Muhungu GL, Mac Kenzie WR, Khan AS, Ndambi R, Noah DL, Rolka HR, Peters CJ, Ksiazek TG. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: Risk factors for patients without a reported exposure. J Infect Dis 1999;179(Suppl 1):S92-7.
  245. Rollin PE, Williams J, Bressler DS, Pearson S, Cottingham M, Pucak G, et al. Ebola-Reston virus among quarantined non-human primates recently imported from the Philippines to the United States. J Infect Dis 1999; 1999;179:S108-S14.
  246. Ropp SL, Esposito JJ, Loparev VN, Palumbo G. Poxviruses infecting humans. In: Manual of Clinical Microbiology, 7th ed. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. eds. Washington, DC: ASM Press;1999:1137-44.
  247. Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, Williams AJ, Peters CJ, Rodriguez L, Feldmann H, Nichol ST, Rollin PE, Ksiazek TG, for the Commission de Lutte Controle des Epidémies à Kikwit. Clinical, virologic and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of Congo. J Infect Dis 1999;179(Suppl 1):S28-35.
  248. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999;37:937-43.
  249. Rupprecht CE. Regional considerations in the treatment of rabies in the U.S. Drugs Ther Perspect 1999;14:9.
  250. Sabouraud A, Smith J, Orciari L, De Mattos C, De Mattos C, Rohde R. Typing of rabies virus isolates by DNA enzyme immunoassay. J Clin Virol 1999;12:9-19.
  251. Sadek RF, Khan AS, Stevens G, Peters CJ, Ksiazek TG. Ebola hemorrhagic fever, Democratic Republic of Congo, 1995: Determinants of survival. J Infect Dis 1999;179(Suppl 1):S18-23.
  252. Sanchez A, Ksiazek TG, Rollin PE, Miranda ME, Trappier SG, Khan AS, Peters CJ, Nichol ST. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis 1999;179 Suppl 1:S164_9.
  253. Sanchez A, Peters CJ, Zaki SR, Rollin P. Filoviruses. In: Guerrant RL, Krogstad DJ, Maguire JA, Walker DH, Weller PF, eds. Tropical Infectious Diseases. New York: Churchill Livingstone, 1999: 1240-52.
  254. Schmid DS, Brown DR, Nisenbaum R, Burke RL, Alexander D, Ashley R, Pellett PE, Reeves WC. Limits in the reliability of gG-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999;37: 376-9.
  255. Schrag S, Rota P, Bellini W. Spontaneous mutation rate of measles virus: Direct estimation based on mutations conferring monoclonal antibody resistance. J Virol 1999;73:51-4.
  256. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among U.S. children, 1980-1995. JAMA 1999;282:1440-7.
  257. Shieh W-J, Edwards C, Spiegel RA, Zaki SR. Spirochetal infections: Leptospirosis. In: Guerrant RL, Krogstad DJ, Maguire JA, Walker DH, Weller PF, eds. Tropical Infectious Diseases. New York: Churchill Livingstone, 1999: 547-55.
  258. Smith J. 1999. Rabies virus. Clinical Microbiology Newsletter. 1999;21:17-23.
  259. Smith, JS. Rabies virus. In: Manual of Clinical Microbiology, seventh edition. PR Murray, EJ Baron, MA Pfaller, FC Tenover, RH Yolken, eds. American Society for Microbiology Press, Washington, DC; 1999:997-1003.
  260. Smith, JS, Neill, SU. Rabies virus. In: Laboratory Diagnosis of Viral Infections, third edition, EH Lennette, TF Smith, eds. Marcel Dekker, New York;1999:745-760.
  261. Stafford KC 3rd, Massung RF, Magnarelli LA, Ijdo JW, Anderson JF. Infection with agents of human granulocytic ehrlichiosis, lyme disease, and babesiosis in wild white-footed mice (Peromyscus leucopus) in Connecticut. J Clin Microbiol. 1999 37:2887-2892.
  262. Stewart JA, Patton JL, and Lennette ET. Chap. 69, Human herpesvirus 6, 7, and 8 and herpes B virus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual Clinical Microbiology, seventh edition. Washington, DC: American Society for Microbiology 1999;919-27.
  263. Stoltenow CL, Shirely LA, Jones T, Rupprecht CE. Atypical rabies in a cow. Bov. Pract. 1999; 33:4-5.
  264. Strickland GT, Olson JG. Ehrlichioses. In: Hunter’s Tropical Medicine, eighth edition. Strickland GT, ed. W.B. Saunders and Co., Orlando, 1999: 445-8.
  265. Subbarao K. Influenza vaccines: present and future. Adv Virus Res 1999;54:349-73.
  266. Sumner JW, Childs JE, Paddock CD. Molecular cloning and characterization of the Ehrlichia chaffeensis variable length PCR target: an antigen-expressing gene that exhibits interstrain variation. J Clin Microbiol 1999;37:1447-53.
  267. Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Reeves WC, Icenogle JP. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 37:1999;1030-4.
  268. Tomori O, Bertolli J, Rollin PE, Fleerackers Y, Guimard Y, De Roo A, Feldmann, Burt F, Swanepoel R, Killian S, Khan AS, Tshioko K, Bwaka M, Ndambe R, Peters CJ, Ksiazek TG. Serological survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(Suppl 1):S98-101.
  269. Tripp R, Moore D, Jones L, Sullender W, Winter J, Anderson L. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol 1999;73:7099-107.
  270. Tsang SX, Switzer WM, Shanmugam V, Johnson JA, Goldsmith C, Wright A, et al. Evidence of avian leukosis virus subgroup E and endogenous avian virus in measles and mumps vaccines derived from chicken cells: Investigation of transmission to vaccine recipients. J Virol 1999; 73:5843-51.
  271. Unicomb LE, Podder G, Gentsch JR, et al. Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995. J Clin Microbiol 1999;37:1885-91.
  272. Unger ER, Vernon DS, Hewan-Lowe K, Lee DR, Meisner JD, Thoms WW, Reeves WC. An unusual cervical carcinoma showing exception to epitheliotropism of human papillomavirus. Human Path 1999;30:483-5.
  273. Vernon SD, Unger ER, Piper MA, Siabailly T, Severin ST, Wiktor SZ, Ghys PD, Miller DL, Greenberg AE, Reeves WC. Risk factors for cervical neoplasia in women with low versus high numbers of sex partners. Sex Trans Infect 1999;75:258-60.
  274. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB et al. Markedly elevated levels of interferon (IFN)-(, IFN-", interleukin (IL)-2, IL-10, and tumor necrosis factor- associated with fatal Ebola virus infection. J Infect Dis 1999; 179:S188-91.
  275. Warner C, Fekadu M, Whitfield S, Shaddock J. Use of anti-glycoprotein monoclonal antibodies to characterize rabies virus in formalin-fixed tissues. J Virol Meth 1999;77:69-74.
  276. Warner CK, Zaki SR, Shieh WJ, Whitfield SG, Smith JS, Orciari LA et al. Laboratory investigation of human deaths from vampire bat rabies in Peru. Am J Trop Med Hyg 1999; 60:502-7.
  277. Watt G, Olson JG. Scrub typhus. In: Hunter’s Tropical Medicine, eighth edition. Strickland, GT, ed. W.B. Saunders and Co., Orlando; 1999; 443-5.
  278. Will RG, Alpers MP, Dormont D, Schonberger LB, Tateishi J. Infectious and sporadic prion diseases. In: Prusiner SB, ed. Prion Biology and Diseases, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1999:465-507.
  279. Willy M, Woodward R, Thornton V, et al. Management of a measles outbreak among Old World nonhuman primates. Lab Animal Med 1999;49:42-8.
  280. Wyatt, J.D., Barker, W.H., Bennett, N.M. and Hanlon,C.A. 1999. The epidemiology of human postexposure prophylaxis in four counties of New York during a raccoon epizootic, 1993 and 1994. Emerg Infect Dis 1999;5: 415-23.
  281. Xu X, Subbarao K, Cox N, Guo Y. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 1999;261:15-9.
  282. Yu YM, Black JB, Goldsmith CS, Browning PJ, Bhalla K, Offerman MK. Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol 1999; 80:83-90.
  283. Zaki SR, Goldsmith C. Pathologic features of filovirus infections in humans. In: Klenk HD, editor. Current Topics in Microbiology and Immunology, Vol. 235 Marburg and Ebola Viruses. Berlin: Springer-Verlag, 1999: 97-116.
  284. Zaki SR, Nolte K. Pathology, Immunohistochemistry and in situ hybridization. Pathology of hantavirus pulmonary syndrome. In: Lee HW, Schmaljohn C, Calisher C, eds. Manual of Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome. Republic of Korea: 1999: 143-54.
  285. Zaki SR, Paddock C. The emerging role of pathology in infectious diseases. In: Horsburgh CR, Nelson AM, editors. Emerging Infections III. Washington: American Society for Microbiology, 1999: 181-200.
  286. Zaki SR, Shieh WJ, Greer PW, Goldsmith CS, Ferebee T, Katshitshi J, et al.. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread and surveillance of Ebola hemorrhagic fever. J Infect Dis 1999;179:S36-S47.
  287. Zheng HQ, Storch GA, Zang C, Peret TCT, Park CS, Anderson LJ. Genetic variability in the envelope-associated protein genes of closely related group A strains of respiratory syncytial virus. Virus Res 1999;59:89-99.
  288. Ziegler T, Hemphill ML, Ziegler M-L, Perez-Oroñoz G, Klimov AI, Hampson AW, Regnery HL, Cox NJ. Low incidence of rimantadine resistance in field isolates of influenza A viruses J Infect Dis 1999;180:935-9.


MMWR Articles 

  1. CDC. Update: Influenza activity – United States, 1998_99 season. MMWR 1999; 48:25_7.
  2. CDC. Final stages of poliomyelitis eradication – Western Pacific Region, 1997_1998. MMWR 1999;48:29_33.
  3. CDC. Human rabies - Virginia, 1998. MMWR 1999;48:95-7.
  4. CDC. Progress toward poliomyelitis eradication – Pakistan,1994_1998. MMWR 48:121_6.
  5. CDC. Update: influenza activity – United States, 1998_99 season. MMWR 1999;48:177_81.
  6. CDC. Progress toward poliomyelitis eradication – South East Asia Region, 1997_1998. MMWR 1999;48:230_2, 239.
  7. CDC. Mass treatment of humans who drank unpasteurized milk from a rabid cow–Massachusetts, 1996 - 1998. MMWR 1999;48:228-9.
  8. CDC. Norwalk_like viral gastroenteritis in U.S. Army trainees – Texas, 1998. MMWR 1999;48:225_7.
  9. CDC. Frequency of vaccine_related and therapeutic injections – Romania, 1998. MMWR 1999;48:271_74.
  10. CDC. Outbreak of Hendra-like virus–Malaysia and Singapore, 1998-1999. MMWR 1999; 48:265-9.
  11. CDC. Progress toward poliomyelitis eradication – Nigeria, 1996_1998. MMWR 1999;48:312_6.
  12. CDC. Update. Outbreak of Nipah virus – Malaysia and Singapore, 1999. MMWR 1999; 48:335-7.
  13. CDC. Update: Influenza activity – United States and worldwide, 1998_99 season, and composition of the 1999_2000 influenza vaccine. MMWR 1999; 48:374_8.
  14. CDC. Progress toward global poliomyelitis eradication – 1997_1998. MMWR 1999; 48:416_21.
  15. CDC. Progress toward poliomyelitis eradication – African region, 1998_April 1999. MMWR 1999;8:513_8.
  16. CDC. Update: Hantavirus pulmonary syndrome – United States, 1999. MMWR 1999;48(no.24):521-525.
  17. CDC. Outbreak of influenza A infection among travelers – Alaska and the Yukon Territory, May_June 1999. MMWR 1999;48:545_6, 555.
  18. CDC. Progress toward measles elimination – southern Africa, 1996_1998. MMWR 1999;48:585_9.
  19. CDC. Intussusception among recipients of rotavirus vaccine – United States, 1998_1999. MMWR 1999;48:577_81.
  20. CDC. Ascertainment of secondary cases of hepatitis A – Kansas, 1996_1997. MMWR 1999; 48:608_10, 619.
  21. CDC. Progress toward poliomyelitis eradication during armed conflict – Somalia and southern Sudan, January 1998_June 1999. MMWR 1999:48;633_7.
  22. CDC. Progress toward the global interruption of wild poliovirus type 2 transmission, 1999. MMWR 1999; 48:736_8, 747.
  23. CDC. Epidemiology of measles – United States, 1998. MMWR 1999;48:749_53.
  24. CDC. Progress toward poliomyelitis eradication – Afghanistan, 1994_1999. MMWR 1999;48:825_9.
  25. CDC. Outbreak of West Nile_like viral encephalitis – New York, 1999. MMWR 1999;48:845_9.
  26. CDC. Update: Influenza activity – worldwide, May_September 1999. MMWR 1999; 48:883_6.
  27. CDC. Update: West Nile_like viral encephalitis – New York, 1999. MMWR 1999;48:890_2.
  28. CDC. Progress toward poliomyelitis eradication – Nepal,1996_1999. MMWR 1999;48:941_4.
  29. CDC. Update: West Nile virus encephalitis – New York, 1999. MMWR 1999;48:944_6, 955.
  30. CDC. Public health response to a potentially rabid bear cub __ Iowa, 1999. MMWR 1999;48:971_3.
  31. CDC. Progress toward poliomyelitis eradication – Myanmar, 1996_1999. MMWR 1999;48:967_71.
  32. CDC. Influenza activity – United States, 1999_2000 season. MMWR 1999; 48:1039_42.
  33. CDC. Progress toward poliomyelitis eradication – Eastern Mediterranean Region, 1998_October 1999. MMWR 1999;48:1057_62, 1071.
  34. CDC. Progress toward measles elimination – Eastern Mediterranean Region, 1980_1998. MMWR 1999;48:1081_6.
  35. CDC. Update: respiratory syncytial virus activity – United States, 1998_1999 season. MMWR 1999;48:1104_6, 1115.
  36. CDC. Global measles control and regional elimination, 1998_1999. MMWR 1999;48:1124_30.


MMWR Recommendations and Reports

  1. CDC. Human Rabies prevention - United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48 (RR-1):1-21.
  2. CDC. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48 (RR_2):1-23.
  3. CDC. Compendium of animal rabies control, 1999. National Association of State Public Health Veterinarians, Inc. MMWR 1999;48 (RR_3):1-9.
  4. CDC. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 48(RR_4):1-28.
  5. CDC. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48 (RR_12):1-37.
  6. CDC. Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR 1999;48(RR-14);1_9.

 

DVRD Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed December 29, 2000

Centers for Disease Control and Prevention
National Center for Infectious Diseases
Division of Viral and Rickettsial Diseases

Privacy Policy | Accessibility